Process View
Any process that modulates the rate, frequency, or extent of cell-substrate junction assembly. Cell-substrate junction assembly is the aggregation, arrangement and bonding together of a set of components to form a junction between a cell and its substrate.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cell substrate junction assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| S100A6 | S100 calcium binding protein A6 | 0.963 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.961 | Human | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.895 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.815 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.713 | Human | |
| ANGPT2 | angiopoietin 2 | 0.672 | ||
| S100B | S100 calcium binding protein B | 0.658 | Human | |
| S100A1 | S100 calcium binding protein A1 | 0.566 | Human | |
| SMAD2 | SMAD family member 2 | 0.548 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.482 | Human | |
| NRP1 | neuropilin 1 | 0.358 | ||
| ANXA2 | annexin A2 | 0.344 | ||
| EGFR | epidermal growth factor receptor | 0.326 | ||
| VEGFA | vascular endothelial growth factor A | 0.317 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.316 | ||
| NCK2 | NCK adaptor protein 2 | 0.307 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.298 | Human | |
| ENG | endoglin | 0.258 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.257 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.255 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.194 | ||
| BMP2 | bone morphogenetic protein 2 | 0.188 | ||
| EPHA7 | EPH receptor A7 | 0.185 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.150 | ||
| SMAD7 | SMAD family member 7 | 0.148 | ||
| S100A11 | S100 calcium binding protein A11 | 0.139 | Human | |
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.138 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.131 | Human | |
| DPYSL4 | dihydropyrimidinase-like 4 | 0.129 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.128 | ||
| EPHA2 | EPH receptor A2 | 0.128 | Human | |
| S100A4 | S100 calcium binding protein A4 | 0.127 | Human | |
| ANGPT1 | angiopoietin 1 | 0.100 | ||
| RHOA | ras homolog gene family, member A | 0.097 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.090 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.086 | Human | |
| GRB7 | growth factor receptor-bound protein 7 | 0.081 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.079 | ||
| EFNA1 | ephrin-A1 | 0.074 | Human | |
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.073 | ||
| AREG | amphiregulin | 0.065 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.063 | ||
| GDF5 | growth differentiation factor 5 | 0.063 | ||
| PDGFC | platelet derived growth factor C | 0.061 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.056 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.052 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.051 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.049 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.046 | ||
| KITLG | KIT ligand | 0.045 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.045 | ||
| JAG1 | jagged 1 | 0.044 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.044 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.039 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.038 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.036 | ||
| TSC2 | tuberous sclerosis 2 | 0.035 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.035 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.032 | ||
| PGF | placental growth factor | 0.032 | Human | |
| HOXA1 | homeobox A1 | 0.032 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.031 | ||
| EFNA5 | ephrin-A5 | 0.031 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.030 | Human | |
| ZNF746 | zinc finger protein 746 | 0.030 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.030 | ||
| LPXN | leupaxin | 0.029 | Human | |
| ACVR1 | activin A receptor, type I | 0.029 | Human | |
| GAB1 | GRB2-associated binding protein 1 | 0.028 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.028 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.027 | Human | |
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.026 | ||
| BMP4 | bone morphogenetic protein 4 | 0.026 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.025 | Rat | |
| S100A2 | S100 calcium binding protein A2 | 0.024 | Human | |
| ILK | integrin-linked kinase | 0.023 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.023 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.022 | Human | |
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.022 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.021 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.020 | ||
| LDLR | low density lipoprotein receptor | 0.020 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.020 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.020 | ||
| CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.020 | ||
| S100A10 | S100 calcium binding protein A10 | 0.020 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.020 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.019 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.019 | ||
| CXXC5 | CXXC finger protein 5 | 0.019 | ||
| LAT | linker for activation of T cells | 0.018 | ||
| LIMK1 | LIM domain kinase 1 | 0.018 | ||
| EPHB3 | EPH receptor B3 | 0.017 | Human | |
| GHR | growth hormone receptor | 0.017 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.017 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.017 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.017 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.016 | ||
| EPHB2 | EPH receptor B2 | 0.016 | Human | |
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.016 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.015 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.015 | Human | |
| EPHA3 | EPH receptor A3 | 0.015 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.015 | ||
| S100P | S100 calcium binding protein P | 0.014 | Human | |
| ITGA7 | integrin, alpha 7 | 0.014 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.014 | ||
| MRAS | muscle RAS oncogene homolog | 0.014 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.014 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.014 | Human | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.014 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.013 | ||
| RHOC | ras homolog gene family, member C | 0.013 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.013 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.013 | ||
| BMP1 | bone morphogenetic protein 1 | 0.013 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.013 | ||
| FHL2 | four and a half LIM domains 2 | 0.013 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.013 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.013 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.013 | Human | |
| PHF21A | PHD finger protein 21A | 0.012 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.012 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.012 | ||
| TSG101 | tumor susceptibility gene 101 | 0.012 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.011 | Human | |
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.011 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.011 | ||
| RHOU | ras homolog gene family, member U | 0.011 | ||
| ZNF426 | zinc finger protein 426 | 0.011 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.011 | ||
| AHNAK | AHNAK nucleoprotein | 0.011 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.011 | ||
| SKIL | SKI-like oncogene | 0.011 | ||
| ACVR1B | activin A receptor, type IB | 0.011 | Human | |
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.010 |